NASDAQ:AKBA

Industry

Akebia Therapeutics Inc [AKBA] fell -28.64% so far this year. What now?

Annabelle Farmer

Akebia Therapeutics Inc [NASDAQ: AKBA] plunged by -$0.04 during the normal trading session on Tuesday and reaching a high of ...

Companies

Akebia Therapeutics Inc [AKBA] Revenue clocked in at $225.07 million, down -14.44% YTD: What’s Next?

Edison Baldwin

Akebia Therapeutics Inc [NASDAQ: AKBA] price plunged by -3.14 percent to reach at -$0.05. A sum of 3906022 shares traded ...

Market

why Akebia Therapeutics Inc [AKBA] is a Good Choice for Investors After New Price Target of $5.80

Annabelle Farmer

Akebia Therapeutics Inc [NASDAQ: AKBA] closed the trading session at $1.67 on 2025-11-10. The day’s price range saw the stock ...

Market

H.C. Wainwright slashes price target on Akebia Therapeutics Inc [AKBA] – find out why.

Edison Baldwin

Akebia Therapeutics Inc [NASDAQ: AKBA] loss -32.04% or -0.99 points to close at $2.1 with a heavy trading volume of ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.